BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30625281)

  • 21. Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD.
    Huo X; Agoston AT; Dunbar KB; Cipher DJ; Zhang X; Yu C; Cheng E; Zhang Q; Pham TH; Tambar UK; Bruick RK; Wang DH; Odze RD; Spechler SJ; Souza RF
    Gut; 2017 Sep; 66(9):1542-1554. PubMed ID: 27694141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
    Palayoor ST; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitors as Anticancer Agents: A Mini-review.
    Lu H; Zhu Y; Liu W; Yan Y; Jiang X; Wang Q; Zhao Y; He M; Wei M
    Curr Med Chem; 2023; 30(25):2835-2849. PubMed ID: 36043744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
    Ajith TA
    J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.
    Jóźwiak P; Ciesielski P; Zaczek A; Lipińska A; Pomorski L; Wieczorek M; Bryś M; Forma E; Krześlak A
    J Biomed Sci; 2017 Oct; 24(1):83. PubMed ID: 29084538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy.
    Martínez-Sáez O; Gajate Borau P; Alonso-Gordoa T; Molina-Cerrillo J; Grande E
    Crit Rev Oncol Hematol; 2017 Mar; 111():117-123. PubMed ID: 28259286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
    J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EPAS1/HIF-2α is a driver of mammalian pexophagy.
    Schönenberger MJ; Krek W; Kovacs WJ
    Autophagy; 2015; 11(6):967-9. PubMed ID: 25997392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
    Pugh CW; Ratcliffe PJ
    Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.
    Hasegawa S; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):331-338. PubMed ID: 30067604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-Inducible Factors and Diabetic Kidney Disease-How Deep Can We Go?
    Stanigut AM; Pana C; Enciu M; Deacu M; Cimpineanu B; Tuta LA
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.
    Xu J; Wang B; Xu Y; Sun L; Tian W; Shukla D; Barod R; Grillari J; Grillari-Voglauer R; Maxwell PH; Esteban MA
    Oncogene; 2012 Feb; 31(8):1065-72. PubMed ID: 21841824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
    Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
    Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron.
    Park SS; Bae I; Lee YJ
    J Cell Biochem; 2008 Apr; 103(6):1989-98. PubMed ID: 17973296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen sensing in intestinal mucosal inflammation.
    Flück K; Fandrey J
    Pflugers Arch; 2016 Jan; 468(1):77-84. PubMed ID: 26206140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIF pathway and erythrocytosis.
    Lee FS; Percy MJ
    Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Roles and molecular mechanisms of hypoxia-inducible factors in renal cell carcinoma].
    Zou JX; Chen K
    Yi Chuan; 2018 May; 40(5):341-356. PubMed ID: 29785943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.